Enhancing Photodynamyc Therapy Efficacy by Combination Therapy: Dated, Current and Oncoming Strategies
Open Access
- 9 June 2011
- Vol. 3 (2), 2597-2629
- https://doi.org/10.3390/cancers3022597
Abstract
Combination therapy is a common practice in many medical disciplines. It is defined as the use of more than one drug to treat the same disease. Sometimes this expression describes the simultaneous use of therapeutic approaches that target different cellular/molecular pathways, increasing the chances of killing the diseased cell. This short review is concerned with therapeutic combinations in which PDT (Photodynamyc Therapy) is the core therapeutic partner. Besides the description of the principal methods used to assess the efficacy attained by combinations in respect to monotherapy, this review describes experimental results in which PDT was combined with conventional drugs in different experimental conditions. This inventory is far from exhaustive, as the number of photosensitizers used in combination with different drugs is very large. Reports cited in this work have been selected because considered representative. The combinations we have reviewed include the association of PDT with anti-oxidants, chemotherapeutics, drugs targeting topoisomerases I and II, antimetabolites and others. Some paragraphs are dedicated to PDT and immuno-modulation, others to associations of PDT with angiogenesis inhibitors, receptor inhibitors, radiotherapy and more. Finally, a look is dedicated to combinations involving the use of natural compounds and, as new entries, drugs that act as proteasome inhibitors.Keywords
This publication has 167 references indexed in Scilit:
- Combination Chemotherapy and Photodynamic Therapy with Fab′ Fragment Targeted HPMA Copolymer Conjugates in Human Ovarian Carcinoma CellsMolecular Pharmaceutics, 2008
- Principles of bioactive lipid signalling: lessons from sphingolipidsNature Reviews Molecular Cell Biology, 2008
- Potentiation of photodynamic therapy of cancer by complement: the effect of γ-inulinBritish Journal of Cancer, 2006
- Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cellsBritish Journal of Cancer, 2006
- Ascorbate enhances the toxicity of the photodynamic action of Verteporfin in HL-60 cellsFree Radical Biology & Medicine, 2006
- Targeted inhibition of p38α MAPK suppresses tumor-associated endothelial cell migration in response to hypericin-based photodynamic therapyBiochemical and Biophysical Research Communications, 2005
- Photochemical Targeting of Epidermal Growth Factor Receptor: A Mechanistic StudyClinical Cancer Research, 2005
- NF-κB in cancer: from innocent bystander to major culpritNature Reviews Cancer, 2002
- Cancer treatment by photodynamic therapy combined with adoptive immunotherapy using genetically altered natural killer cell lineInternational Journal of Cancer, 2001
- Clinical Pharmacokinetics of DocetaxelClinical Pharmacokinetics, 1999